Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
John D Imig1, Christophe Morisseau2
1Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, United States.
Frontiers in Pharmacology
|October 19, 2020
Abstract
No abstract available in PubMed .
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.9K
13:05Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
8.5K
